Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Crucell Getting STAR Technology Through ChromaGenics Purchase

March 17, 2004

By Cormac Sheridan

BioXell Brings In EUR7.3M For R&D Through Grant, Loan

March 17, 2004

By Cormac Sheridan

Medivir Seeking SEK322M In Discounted Rights Issue

March 17, 2004

By Cormac Sheridan

BioTie Gains Ground On News Of Bioheparin Deal With Aventis

March 10, 2004

By Cormac Sheridan

Basilea Moving Infection Drug Into Phase III, Launching IPO

March 10, 2004

By Cormac Sheridan

BioTie Gains Ground On News Of Bioheparin Deal With Aventis

March 10, 2004

By Cormac Sheridan

Basilea Moving Infection Drug Into Phase III, Launching IPO

March 10, 2004

By Cormac Sheridan

Active Biotech Cuts Work Force; Focus Now On Current Portfolio

March 3, 2004

By Cormac Sheridan

Active Biotech Cuts Work Force; Focus Now On Current Portfolio

March 3, 2004

By Cormac Sheridan

Borean Pharma Brings In ApoA-I Project Via Proteopharma Buyout

Feb. 25, 2004

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...